Tag: <span>Pharmacology of calcitonin/CGRP</span>

Home / Pharmacology of calcitonin/CGRP
Post

FDA expands warning against use of blood pressure drug

Patients taking affected medication should contact their pharmacist or physician. Arutz Sheva Staff The US Food and Drug Adminsitration (FDA) and Torrent Pharmaceuticals Limited expanded for the fifth time a warning against using a common blood pressure medication. The medication, Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, is being recalled to the consumer level due to detection of trace amounts of...

Post

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Abstract The calcitonin/CGRP family of peptides includes calcitonin, α and β CGRP, amylin, adrenomedullin (AM) and adrenomedullin 2/intermedin (AM2/IMD). Their receptors consist of one of two GPCRs, the calcitonin receptor (CTR) or the calcitonin receptor‐like receptor (CLR). Further diversity arises from heterodimerization of these GPCRs with one of three receptor activity‐modifying proteins (RAMPs). This gives...